HBV-IN-39-d3, CAS 2173356-23-3

Product Description: HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13). HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better oral bioavailability than HBV-IN-39[1].

Applications: COVID-19-anti-virus

Formula: C23H25D3FNO6

References: [1]Yi Chen, et al. Therapeutic agents for the treatment of HBV infection. Patent CN110240596B.

CAS Number: 2173356-23-3

Molecular Weight: 436.49

Research Area: Infection

Solubility: 10 mM in DMSO

Target: HBV

• SKU: MEXHY-156703S-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-156703S-1
• Package Unit: 1 mg
• Quantity Unit: STK